radioactive diagnostic agents for use with PET imaging

 are improving identification of beta-amyloid, the brain plaque associated with Alzheimer’s disease. But there are some concerns that radiologists and technologists don’t have enough training to accurately read these PET studies. What do you think?

 CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.

New diagnostic agents for use with PET imaging are improving identification of beta-amyloid, the brain plaque associated with Alzheimer’s disease. But there are some concerns about training to accurately read these studies.

Poll of the Week: Reading PET Studies for Alzheimer's?